Connect with me on LinkedIn!
Research Identity & Protocol Management
A centralized view of active clinical research protocols, ORCID-verified identity, and institutional record tracking — designed for precision, transparency, and research accountability.
Researcher Identity
ORCID-Verified Academic Profile
ORCID iD
This unique persistent identifier distinguishes this researcher from every other investigator and ensures that their contributions to science are reliably attributed — across institutions, name changes, and international boundaries.
ORCID (Open Researcher and Contributor ID) is the global standard for researcher identification, recognized by journals, funders, and academic institutions worldwide. Connecting publications, grants, and protocols to a single verified identity enables seamless, trustworthy scholarly communication.
Why ORCID Matters
Persistent Identity
Survives institutional changes, name updates, and career transitions
Global Recognition
Accepted by thousands of journals, funders, and research systems
Verified Attribution
Ensures credit for all scholarly and clinical contributions
Active Research Portfolio
Clinical Protocol Record Overview
The protocol record list provides a structured, real-time view of all active, in-progress, and released clinical trials under this researcher's purview. Each record is uniquely identified and mapped to ClinicalTrials.gov where applicable, ensuring full transparency and regulatory alignment.
Study Spotlight
Featured Active Protocols
HHI-INS-AUT-OBS-2025-001
Intranasal Insulin for Autism Spectrum Disorder — A study investigating insulin delivery in children and young adults aged 4–21 years (IN-INS-AUT). Currently In Progress.
MUSE-OVARY-001
Intra Ovarian Muse Cell Injection for Perimenopause — Symptom relief and ovarian function restoration (MUSE-OVARY). Status: Released. Linked to ClinicalTrials.gov.
HHI-ND-OBS-2025-001
Intensive Multimodal Neurorehabilitation — Targeting neuroplasticity in pediatric neurodevelopmental and chromosomal disorders (GEN-HOPE). ClinicalTrials.gov: NCT07493096.
Gene Therapy Research
Advanced Therapeutic Interventions
HHI-HIE-OBS-2025-001
Intranasal AAV9-PrPeB Gene Therapy in Cerebral Palsy (CP) and Hypoxic Ischemic Encephalopathy (HIE) — GEN-HGPE
ClinicalTrials.gov: NCT07264166
Status: Public
HHI-TBI-MUSE-001
Safety and Outcomes of MUSE Stem Cell Therapy in individuals with Traumatic Brain Injury (MUSE-TBI-OBS)
ClinicalTrials.gov: NCT07326059
Status: Public
Both studies represent cutting-edge interventional research in neurological recovery and regenerative medicine.
Regenerative Medicine
MUSE Stem Cell Research Program
The MUSE (Multilineage-differentiating Stress Enduring) cell research program spans two active protocols — targeting traumatic brain injury recovery and ovarian function restoration. These studies represent a significant frontier in regenerative and restorative medicine, exploring the body's own pluripotent stem cells as a therapeutic mechanism.
MUSE-TBI-OBS
Safety and outcomes monitoring for stem cell therapy post-traumatic brain injury
MUSE-OVARY
Intraovarian MUSE cell injection for perimenopause symptom relief and function restoration
Shared Goal
Harnessing endogenous pluripotent stem cells to restore tissue function without immune rejection
COVID-19 Research
HHI-IVIG-LC001 — Observational IVIG Study in Severe SARS-CoV-2
Study Overview
This observational protocol examines the use of Intravenous Immunoglobulin (IVIG) therapy in patients with severe acute respiratory syndrome caused by SARS-CoV-2. The study follows patients undergoing medical management to evaluate outcomes, safety signals, and immune response patterns.
ClinicalTrials.gov: NCT06992401 | Status: Public

This study contributes to the growing body of evidence on immunomodulatory approaches in severe COVID-19, with implications for future pandemic preparedness protocols.
Protocol Status at a Glance
Across all active records, this research portfolio reflects a diverse and rigorous commitment to clinical investigation — spanning gene therapy, stem cell biology, neurorehabilitation, and immunology.
6
Active Protocols
Unique research studies currently tracked and managed
5
ClinicalTrials.gov IDs
Federally registered trials with public visibility
4
Therapeutic Areas
Neurology, regenerative medicine, women's health, and immunology
1
ORCID iD
Verified persistent researcher identity across all contributions
Record Management
Institutional Protocol Tracking System
The record management interface — as visible in the protocol record list — provides administrators and investigators with a structured, searchable view of all registered studies. Key capabilities include:
Unique Protocol IDs
Each study is assigned a structured institutional identifier for unambiguous tracking across departments and regulatory bodies.
Problem Resolution Flags
The system surfaces data quality issues — such as incomplete entries or unreleased records — enabling proactive resolution before submission.
ClinicalTrials.gov Linkage
Direct mapping between institutional records and federal registry IDs ensures regulatory compliance and public transparency.
Record Status Tracking
Statuses such as In Progress, Released, and Public provide real-time visibility into each protocol's lifecycle stage.
Verified Identity
Connect With This Researcher
All publications, grants, protocols, and scholarly outputs associated with this investigator are linked through a single, verified ORCID identity. Whether you are a collaborator, journal editor, funding agency, or research administrator, the ORCID profile provides the authoritative source for this researcher's academic record.

orcid.org

ORCID

ORCID Profile: 0000-0001-8213-6953